In January, the clinical trial of our DNA vaccine for Covid-19 - 100% made in Italy - will begin at the research center of the San Gerardo Hospital in Monza, with the Pascale Institute of Naples which coordinates the experimentation and collaboration of the Spallanzani in Rome.
Our technology differs from that of the vaccines that will be approved first. Such diversity can be an advantage for our candidate in terms of repeatability and duration of the immune response.

Look at the video on SKYTg24